Keith A Kucinski - Net Worth and Insider Trading
Keith A Kucinski Net Worth
The estimated net worth of Keith A Kucinski is at least $979 dollars as of 2024-12-28. Keith A Kucinski is the CFO of Matinas BioPharma Holdings Inc and owns about 1,890 shares of Matinas BioPharma Holdings Inc (MTNB) stock worth over $979. Details can be seen in Keith A Kucinski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Keith A Kucinski has not made any transactions after 2019-11-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Keith A Kucinski
Keith A Kucinski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith A Kucinski owns 1 companies in total, including Matinas BioPharma Holdings Inc (MTNB) .
Click here to see the complete history of Keith A Kucinski’s form 4 insider trades.
Insider Ownership Summary of Keith A Kucinski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MTNB | Matinas BioPharma Holdings Inc | 2019-11-25 | Chief Financial Officer |
Keith A Kucinski Latest Holdings Summary
Keith A Kucinski currently owns a total of 1 stock. Keith A Kucinski owns 1,890 shares of Matinas BioPharma Holdings Inc (MTNB) as of November 25, 2019, with a value of $979.
Latest Holdings of Keith A Kucinski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MTNB | Matinas BioPharma Holdings Inc | 2019-11-25 | 1,890 | 0.52 | 979 |
Holding Weightings of Keith A Kucinski
Keith A Kucinski Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith A Kucinski has made a total of 0 transactions in Matinas BioPharma Holdings Inc (MTNB) over the past 5 years. The most-recent trade in Matinas BioPharma Holdings Inc is the acquisition of 1,890 shares on November 25, 2019, which cost Keith A Kucinski around $115,290.
Insider Trading History of Keith A Kucinski
- 1
Keith A Kucinski Trading Performance
GuruFocus tracks the stock performance after each of Keith A Kucinski's buying transactions within different timeframes. To be detailed, the average return of stocks after 1 year bought by Keith A Kucinski is -20.16%. GuruFocus also compares Keith A Kucinski's trading performance to market benchmark return within the same time period. The performance of stocks bought by Keith A Kucinski within 1 year outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Keith A Kucinski's insider trading performs compared to the benchmark.
Performance of Keith A Kucinski
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 57.52 | | | | | |
| Relative Return to S&P 500(%) | 54.66 | | | | | |
Keith A Kucinski Ownership Network
Keith A Kucinski Owned Company Details
What does Matinas BioPharma Holdings Inc do?
Who are the key executives at Matinas BioPharma Holdings Inc?
Keith A Kucinski is the Chief Financial Officer of Matinas BioPharma Holdings Inc. Other key executives at Matinas BioPharma Holdings Inc include Chief Business Officer Thomas Hoover , director & Chief Executive Officer Jerome D Jabbour , and Chief Medical Officer Ferguson James J. Iii .
Matinas BioPharma Holdings Inc (MTNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Matinas BioPharma Holdings Inc (MTNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Matinas BioPharma Holdings Inc (MTNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Matinas BioPharma Holdings Inc (MTNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Matinas BioPharma Holdings Inc Insider Transactions
Keith A Kucinski Mailing Address
Above is the net worth, insider trading, and ownership report for Keith A Kucinski. You might contact Keith A Kucinski via mailing address: C/o Matinas Biopharma Holdings Inc., 1545 Rt. 206 South, Suite 302, Bedminster Nj 07921.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
